Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
158,189
-
Share change
-
+20,219
-
Total reported value
-
$282,029
-
Price per share
-
$1.78
-
Number of holders
-
10
-
Value change
-
+$35,951
-
Number of buys
-
5
-
Number of sells
-
3
Institutional Holders of Innate Pharma SA - SPONSORED ADS (IPHA) as of Q1 2025
As of 31 Mar 2025,
Innate Pharma SA - SPONSORED ADS (IPHA) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
158,189 shares.
The largest 10 holders included
EXCHANGE TRADED CONCEPTS, LLC, MORGAN STANLEY, CITADEL ADVISORS LLC, MILLENNIUM MANAGEMENT LLC, UBS Group AG, GAMMA Investing LLC, RHUMBLINE ADVISERS, BARCLAYS PLC, Optiver Holding B.V., and Tower Research Capital LLC (TRC).
This page lists
10
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.